DORM insider filing: 1,213 shares to be sold via Fidelity on NASDAQ
Rhea-AI Filing Summary
Dorman Products (DORM) filed a Form 144 proposing the sale of 1,213 shares of common stock through Fidelity Brokerage Services on NASDAQ with an aggregate market value of $181,950 and an approximate sale date of 08/12/2025. The filing shows those 1,213 shares were acquired on 02/28/2025 through restricted stock vesting and paid as compensation on the same date.
The filing lists total shares outstanding of 30,534,243 and discloses a prior sale on 07/28/2025 of 820 shares that generated $100,211.63. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider notice for vested restricted shares; transaction size appears modest relative to total shares outstanding.
The Form 144 reports a proposed sale of 1,213 common shares valued at $181,950, acquired by restricted stock vesting on 02/28/2025. The filing also records a recent sale of 820 shares on 07/28/2025 with proceeds of $100,211.63. This filing is a standard disclosure mechanism for selling restricted or affiliate-held securities and, based on the figures provided, does not by itself indicate a material change to the company's capital structure or operations.
TL;DR: Filing demonstrates compliance with resale notification requirements and includes the customary seller representation about material information.
The document identifies the broker (Fidelity Brokerage Services LLC) and the approximate sale date (08/12/2025) and confirms the shares were issued via restricted stock vesting as compensation. It also discloses a recent disposal of shares, which supports transparency about insider trading activity. The included representation about absence of undisclosed material adverse information is the standard attestation required on this form.